FIDELIS iM’s Merck MRK Stock Holding History

FIDELIS iM’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,500	Closed	-$277K	–	20
2022 Q4	$277K	Hold	2,500	–	–	0.18%	20
2022 Q3	$215K	Hold	2,500	–	–	0.15%	21
2022 Q2	$228K	Hold	2,500	–	–	0.15%	21
2022 Q1	$205K	Buy	+2,500	New	+$197K	0.12%	23

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FIDELIS iM's MRK Position: Q1 2023 in Review

FIDELIS iM sold out of Merck (MRK) in Q1 2023, closing a stake of 2,500 shares — an estimated $277K sold.

FIDELIS iM first reported a position in MRK in Q1 2022 and held it in 4 quarters. The position peaked at $277K in Q4 2022. 3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

FIDELIS iM reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
FIDELIS iM sold 2,500 Merck shares in Q1 2023, an estimated $277K.
FIDELIS iM first reported a position in Merck in Q1 2022 and held it in 4 quarters.
FIDELIS iM's Merck position peaked at $277K in Q4 2022.
3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on FIDELIS iM's 13F filing for Q1 2023, filed 26 Apr 2023.